Abstract 1702: Androgen receptor antagonist bicalutamide sensitizes androgen-independent prostate cancer cells to mTOR inhibitor rapamycin by regulating phosphorylation of translation initiation suppressor eIF4E-binding protein 1 (4E-BP1)
2017 ◽
Vol 275
◽
pp. 22-34
◽
2014 ◽
Vol 207
◽
pp. 16-22
◽
2007 ◽
Vol 357
(2)
◽
pp. 341-346
◽
2007 ◽
Vol 67
(17)
◽
pp. 8388-8395
◽
2020 ◽
Vol 38
(5)
◽
pp. 1292-1302
◽
2005 ◽
Vol 65
(17)
◽
pp. 8003-8008
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. e15049-e15049
◽
Keyword(s):
Keyword(s):